RxDoctor Payments Data

Calvin Tebbe, DO

Family Medicine · Grand Haven, MINPI 1326572702

Payments from drug & device makers

$967in general payments, 2019–2025

Across 50 payments — averaging $19.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$360
  • Novo Nordisk$196
  • Astellas Pharma US Inc$86
  • GSK$80
  • Sanofi$74
  • AstraZeneca$58
  • plus $115 from 6 others

What the payments were for

  • Food & beverage$967100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$967 in reported general payments places this provider in the 70th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$43,121
Medicare patients
119
Services billed
526

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin56$64,616
EliquisApixaban53$58,547
JanuviaSitagliptin Phosphate32$43,907
TrulicityDulaglutide23$40,216
OzempicSemaglutide14$28,143
MounjaroTirzepatide20$24,229
FarxigaDapagliflozin Propanediol19$15,373
Atorvastatin Calcium318$5,139
Levothyroxine Sodium178$3,418
Losartan Potassium167$2,862
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide77$2,017
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$1,943
Lisinopril143$1,871
Metoprolol Succinate88$1,749
Omeprazole94$1,674

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$13$64,44543 claims
PfizerEliquis$360$58,54753 claims
Novo NordiskOzempic$196$28,14314 claims
AstraZenecaFarxiga$58$15,37319 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Grand Haven

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →